BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10919900)

  • 1. A randomized, double-masked trial of topical ketorolac versus artificial tears for treatment of viral conjunctivitis.
    Shiuey Y; Ambati BK; Adamis AP
    Ophthalmology; 2000 Aug; 107(8):1512-7. PubMed ID: 10919900
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Artificial tears alone versus 0.45% ketorolac tromethamine with artificial tears for the treatment of acute viral conjunctivitis.
    Lyra AF; Bastos LC; Lima RC; Maranhão Lde V; Arantes TE
    Arq Bras Oftalmol; 2014 Apr; 77(2):99-102. PubMed ID: 25076474
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dexamethasone/Povidone Eye Drops versus Artificial Tears for Treatment of Presumed Viral Conjunctivitis: A Randomized Clinical Trial.
    Pinto RD; Lira RP; Abe RY; Zacchia RS; Felix JP; Pereira AV; Arieta CE; de Castro RS; Bonon SH
    Curr Eye Res; 2015 Sep; 40(9):870-7. PubMed ID: 25310347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of topical ketorolac and indomethacin on measles conjunctivitis: randomized controlled trial.
    Toker MI; Erdem H; Erdogan H; Arici MK; Topalkara A; Arslan OS; Pahsa A
    Am J Ophthalmol; 2006 May; 141(5):902-905. PubMed ID: 16527227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomised, double-blind trial of topical ketorolac vs artificial tears for the treatment of episcleritis.
    Williams CP; Browning AC; Sleep TJ; Webber SK; McGill JI
    Eye (Lond); 2005 Jul; 19(7):739-42. PubMed ID: 15359265
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical indomethacin solution versus dexamethasone solution for treatment of inflamed pterygium and pinguecula: a prospective randomized clinical study.
    Frucht-Pery J; Siganos CS; Solomon A; Shvartzenberg T; Richard C; Trinquand C
    Am J Ophthalmol; 1999 Feb; 127(2):148-52. PubMed ID: 10030555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-masked, paired-comparison clinical study of ketorolac tromethamine 0.5% ophthalmic solution compared with placebo eyedrops in the treatment of seasonal allergic conjunctivitis.
    Tinkelman DG; Rupp G; Kaufman H; Pugely J; Schultz N
    Surv Ophthalmol; 1993; 38 Suppl():133-40. PubMed ID: 8236004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative evaluation of olopatadine 0.01% combined fluorometholone 0.1% treatment versus olopatadine 0.01% combined ketorolac 0.4% treatment in patients with acute seasonal allergic conjunctivitis.
    Celik T; Turkoglu EB
    Curr Eye Res; 2014 Jan; 39(1):42-6. PubMed ID: 24074291
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the topical ocular antiallergic efficacy of emedastine 0.05% ophthalmic solution to ketorolac 0.5% ophthalmic solution in a clinical model of allergic conjunctivitis.
    Discepola M; Deschenes J; Abelson M
    Acta Ophthalmol Scand Suppl; 1999; (228):43-6. PubMed ID: 10337432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of inflamed pterygium and pinguecula with topical indomethacin 0.1% solution.
    Frucht-Pery J; Solomon A; Siganos CS; Shvartzenberg T; Richard C; Trinquand C
    Cornea; 1997 Jan; 16(1):42-7. PubMed ID: 8985633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Topical ketorolac 0.5% solution for the treatment of vernal keratoconjunctivitis.
    Sharma A; Gupta R; Ram J; Gupta A
    Indian J Ophthalmol; 1997 Sep; 45(3):177-80. PubMed ID: 9475021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of the effects of ketotifen fumarate 0.025% and olopatadine HCl 0.1% ophthalmic solutions in seasonal allergic conjunctivities: a 30-day, randomized, double-masked, artificial tear substitute-controlled trial.
    Avunduk AM; Tekelioglu Y; Turk A; Akyol N
    Clin Ther; 2005 Sep; 27(9):1392-402. PubMed ID: 16291412
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketorolac versus prednisolone versus combination therapy in the treatment of acute pseudophakic cystoid macular edema.
    Heier JS; Topping TM; Baumann W; Dirks MS; Chern S
    Ophthalmology; 2000 Nov; 107(11):2034-8;discussion 2039. PubMed ID: 11054327
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical ketorolac in vitreoretinal surgery: a prospective, randomized, placebo-controlled, double-masked trial.
    Kim SJ; Lo WR; Hubbard GB; Srivastava SK; Denny JP; Martin DF; Yan J; Bergstrom CS; Cribbs BE; Schwent BJ; Aaberg TM
    Arch Ophthalmol; 2008 Sep; 126(9):1203-8. PubMed ID: 18779478
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical evaluation of ketorolac tromethamine 0.5% ophthalmic solution for the treatment of seasonal allergic conjunctivitis.
    Ballas Z; Blumenthal M; Tinkelman DG; Kriz R; Rupp G
    Surv Ophthalmol; 1993; 38 Suppl():141-8. PubMed ID: 8236005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of ozonized oil and a combination of tobramycin/dexamethasone eye drops in the treatment of viral conjunctivitis: a randomized clinical trial.
    Cagini C; Mariniello M; Messina M; Muzi A; Balducci C; Moretti A; Levorato L; Mencacci A
    Int Ophthalmol; 2020 Dec; 40(12):3209-3215. PubMed ID: 32696102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification.
    Almeida DR; Khan Z; Xing L; Bakar SN; Rahim K; Urton T; El-Defrawy SR
    J Cataract Refract Surg; 2012 Sep; 38(9):1537-43. PubMed ID: 22795976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative study on the efficacy of non-steroidal, steroid and non-use of anti-inflammatory in the treatment of acute epidemic conjunctivitis.
    Santiago LA; Silva JMRD; Azevedo OGR; Vasconcelos PRL
    Acta Cir Bras; 2020; 34(12):e201901206. PubMed ID: 32049186
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Topical non-steroidal anti-inflammatory drugs in allergic conjunctivitis: meta-analysis of randomized trial data.
    Swamy BN; Chilov M; McClellan K; Petsoglou C
    Ophthalmic Epidemiol; 2007; 14(5):311-9. PubMed ID: 17994441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A multicenter comparison of the ocular efficacy and safety of diclofenac 0.1% solution with that of ketorolac 0.5% solution in patients with acute seasonal allergic conjunctivitis.
    Tauber J; Raizman MB; Ostrov CS; Laibovitz RA; Abelson MB; Betts JG; Koester JM; Gill D; Schaich L
    J Ocul Pharmacol Ther; 1998 Apr; 14(2):137-45. PubMed ID: 9572539
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.